Global Information
회사소개 | 문의 | 비교리스트

RNA 시퀀싱 시장 : 제2판

The Market for RNA Sequencing, 2nd Edition

리서치사 Kalorama Information
발행일 2022년 09월 상품코드 1123760
페이지 정보 영문 59 Pages 배송안내 1-2일 (영업일 기준)
가격
US $ 4,500 ₩ 6,392,000 Online Access (Single User License)
US $ 6,750 ₩ 9,589,000 Online Access & PDF Download (10 Users)
US $ 9,000 ₩ 12,785,000 Online Access & PDF Download (Unlimited Users)


RNA 시퀀싱 시장 : 제2판 The Market for RNA Sequencing, 2nd Edition
발행일 : 2022년 09월 페이지 정보 : 영문 59 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

시퀀싱 시장은 의료에 큰 변화를 초래할 가능성을 내포한 강력한 툴을 계속 제공하고 있습니다. 과거 10년간 제품의 도입, 새로운 용도, 그리고 이 새로운 분야로의 참여를 서두르는 최종사용자 랩이라는 점에서 폭발적인 성장이 발생했습니다. 최근 RNA 시퀀싱이 이것을 대신하여 능가하게 되었으므로 RNA 발현 해석을 위한 마이크로어레이의 사용은 크게 감소하고 있습니다.

RNA 시퀀싱 제품(하드웨어, 하드웨어의 서비스, 소프트웨어, 시퀀싱 스텝 자체를 포함한 소모품) 시장에 초점을 맞추고 동향, 과제, 전략, 기업, 제품에 대해 논의하며, 시장 점유율과 매출 성장률에 대한 추정을 정리하여 전해드립니다.

조사 내용 :

  • RNA 시퀀싱 시장(2021년·2026년)
  • RNA 시퀀싱 소모품 시장(2021년·2026년)
  • RNA 시퀀싱 장비 관련 서비스 시장(2021년·2026년)
  • RNA 시퀀싱 소프트웨어 시장(2021년·2026년)
  • RNA 시퀀싱 벤더 점유율
  • 출시 제품
  • 소프트웨어 제품
  • 혁신
  • 임상 시퀀싱과 출시 제품

목차

제1장 개요

제2장 시장 동향

  • 서론
  • 동향
  • 임상 진단, 임상 연구 용도
  • 암 - 백혈병/혈액 질환, 고형 종양
  • 감염증
  • 희소 유전/유전성 질환
  • COVID-19
  • Illumina의 다양한 제품군
  • 기타 기업의 NGS 제품과 기술
  • CDC의 SPHERE Consortium
  • 지속적 신제품의 도입
  • 싱글 셀 RNA 시퀀싱
  • 주요 제품/기술
  • 소프트웨어/바이오인포매틱스
  • 많은 분야에서의 파트너십, 인수, 거래

제3장 시장 분석

  • 시장 분석
  • 시장 점유율

제4장 기업 개요

  • Illumina
  • Thermo Fisher Scientific
  • New England Biolabs
  • 10X Genomics
  • Agilent Technologies
  • Takara Bio Inc.
  • Oxford Nanopore Technologies
  • NuGen(Tecan)
  • Pacific Biosciences of California, Inc.(PacBio)
  • Standard BioTools
KSA 22.09.22

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which has been the gold standard, there is a need for pre-defined probes which creates one of the major weaknesses of microarrays, and RNA-seq provides a number of advantages including:

  • improved sensitivity and dynamic range
  • ability to study species without reference
  • measurement of focal changes (such as single nucleotide variants, insertions and deletions)
  • detection of different transcript isoforms, splice variants and chimeric gene fusions (including previously unidentified genes and/or transcripts)

This report, “The Market for RNA Sequencing, 2nd Edition ”, focuses on the market for RNA sequencing products - the hardware, service of the hardware, software, and consumables including for the sequencing step itself. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market.

Information in this report includes:

  • RNA Sequencing Market, 2021 and 2026
  • RNA Sequencing Consumables Market, 2021 and 2026
  • RNA Sequencing Equipment-Related Services Market, 2021 and 2026
  • RNA Sequencing Software Market, 2021 and 2026
  • RNA Sequencing Vendor Share
  • Products on The Market
  • Software Products
  • Innovations
  • Clinical Sequencing and Products on the Market

The competitive situation, deals, and litigation are covered in respective chapters. The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

Companies Profiled Include:

  • Illumina
  • Agilent
  • 10X Genomics
  • Oxford Nanopore
  • Thermo
  • Roche
  • Qiagen
  • and Others

Table of Contents

Chapter 1: Executive Summary

  • Table 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (in millions of $)
  • Figure 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
  • Scope and Methodology
  • Report Structure

Chapter 2: Market Trends

  • Introduction
  • Trends
  • Clinical Diagnostics, Clinical Research Applications
  • Cancer - leukemia/ hematological diseases; solid tumors
  • Infectious diseases
  • Rare inherited/ genetic diseases
    • Table 2-1: Selected RNA-Seq Diagnostic/ Clinical Products and Technologies
  • COVID-19
  • Illumina's Diverse Range of Products
  • Other Companies' NGS Products and Technologies
  • CDC's SPHERES Consortium
  • Ongoing Introductions of New Products
    • Table 2-2: RNA-Sequencing Product Introductions, August 2017- August 2022
  • Single-Cell RNA Sequencing
  • Selected Products/ Technologies
    • Table 2-3: Selected RNA-Seq Products and Technologies
  • Software/ Bioinformatics
    • Table 2-4: Selected RNA-Seq Software and Related IT Tools
  • Partnerships, Acquisitions, Deals in Many Areas
    • Table 2-5: RNA-Seq Collaborations, Acquisitions and Other Deals

Chapter 3: Market Analysis

  • Market Analysis
    • Table 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
    • Figure 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
    • Table 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (percent)
    • Figure 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
    • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
  • Market Shares
    • Table 3-3: RNA Sequencing Market Revenue Share, by Leading Companies (Illumina, Thermo, and Other), 2021 (millions of dollars and percent)
    • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
    • Table 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (millions of dollars and percent)
    • Figure 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (percent)

Chapter 4: Company Profiles

  • Illumina
  • Thermo Fisher Scientific
  • New England Biolabs
  • 10X Genomics
  • Agilent Technologies
  • Takara Bio Inc.
  • Oxford Nanopore Technologies
  • NuGen (Tecan)
  • Pacific Biosciences of California, Inc. (PacBio)
  • Standard BioTools
Back to Top
전화 문의
F A Q